There were 9,846 registered participants for #SABCS21 and 1,991 of those were in person.

Olufunmilayo Olopade, MD's lecture title will be, "Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention."

More than 9,300 people registered for the 43rd Annual San Antonio Breast Cancer Symposium. The attendance for the virtual event exceeded in-person attendance by nearly 2,000.

The virtual San Antonio Breast Cancer Symposium provides the same great content, just in a different way.

Dr. Virginia Kaklamani talks about how she and her colleagues have been dealing with the pandemic.

The preliminary program including educational lectures, plenary lectures, and mini-symposia is now available on the SABCS website.

SABCS 2018 is the last one for Symposium Director Rich Markow.

The latest updates on advances in translational research will be presented during a dozen educational sessions slated for the first full day of the San Antonio Breast Cancer Symposium® (SABCS®) Dec. 4-8.Beginning at 2 p.m. Dec. 4, attendees can hear presentations on a number of topics including HER2, metastasis biology, metabolic reprogramming, and recurrence in ER positive breast cancer.“These educational sessions are extremely important,” said SABCS Co-Director, Virginia Ka...

Nicholas Navin, PhD and Ingrid Mayer, MD, MCSI will present the plenary lectures at the 2018 San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8.